| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0065-2776(07)95005-1 |
| P698 | PubMed publication ID | 17869613 |
| P2093 | author name string | Jean-Pierre David | |
| P2860 | cites work | Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 | Q22010683 |
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 | ||
| IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL | Q24338171 | ||
| Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis | Q24564656 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice | Q28140546 | ||
| TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src | Q28142620 | ||
| The TNF and TNF receptor superfamilies: integrating mammalian biology | Q28203717 | ||
| Interferons, immunity and cancer immunoediting | Q28270336 | ||
| Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency | Q28284581 | ||
| TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Osteoblastic cells regulate the haematopoietic stem cell niche | Q29615007 | ||
| Identification of the haematopoietic stem cell niche and control of the niche size | Q29615008 | ||
| Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice | Q47776871 | ||
| TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. | Q50335956 | ||
| Connection between B lymphocyte and osteoclast differentiation pathways. | Q52130852 | ||
| Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 | ||
| Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. | Q54784059 | ||
| Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells | Q57184743 | ||
| RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β | Q57675150 | ||
| Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 | Q57675161 | ||
| Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling | Q58085461 | ||
| JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms | Q58326878 | ||
| Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP | Q58326934 | ||
| c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 | ||
| Bone and haematopoietic defects in mice lacking c-fos | Q58326969 | ||
| T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ | Q59064307 | ||
| Therapeutic targeting of a stem cell niche | Q61802299 | ||
| Pleiotropic effects of a null mutation in the c-fos proto-oncogene | Q62555352 | ||
| Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis | Q73067239 | ||
| Activated T lymphocytes support osteoclast formation in vitro | Q73149439 | ||
| Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta ) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast forma | Q74148039 | ||
| Tumor necrosis factor alpha-induced osteoclastogenesis requires tumor necrosis factor receptor-associated factor 6 | Q74488822 | ||
| Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction | Q75288496 | ||
| Dickkopf-1 is a master regulator of joint remodeling | Q79610564 | ||
| Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells | Q81676385 | ||
| Signalling pathways of the TNF superfamily: a double-edged sword | Q29616428 | ||
| Genetic regulation of osteoclast development and function | Q29617421 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia | Q33853506 | ||
| Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction | Q33886695 | ||
| Stepwise reprogramming of B cells into macrophages | Q33978638 | ||
| Hematopoiesis is severely altered in mice with an induced osteoblast deficiency | Q34290169 | ||
| Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins | Q34451039 | ||
| Reaching a genetic and molecular understanding of skeletal development | Q34611297 | ||
| Osteoclasts are essential for TNF-alpha-mediated joint destruction | Q34826003 | ||
| Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis | Q34967810 | ||
| Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 | ||
| IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation | Q35219971 | ||
| Inflammatory Mediators as Essential Elements in Bone Remodeling | Q35562458 | ||
| Bone loss in inflammatory arthritis: mechanisms and treatment strategies | Q35808004 | ||
| Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease | Q36282334 | ||
| Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones | Q36316526 | ||
| B cells and osteoblast and osteoclast development | Q36324944 | ||
| Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses | Q36400158 | ||
| Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size | Q36403763 | ||
| Determinants of lymphoid-myeloid lineage diversification | Q36427387 | ||
| Stromal niches, plasma cell differentiation and survival. | Q36450001 | ||
| The stem cell niches in bone | Q36467113 | ||
| Cytokines regulating osteoclast formation and function | Q36501069 | ||
| Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition. | Q36569101 | ||
| Dissociation between bone resorption and bone formation in osteopenic transgenic mice | Q36800774 | ||
| TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand | Q37413745 | ||
| Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors | Q39804736 | ||
| IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB | Q39946703 | ||
| Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells | Q40277201 | ||
| Regulation of cancer cell migration and bone metastasis by RANKL. | Q40298349 | ||
| Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors | Q40489394 | ||
| TRAF5 functions in both RANKL- and TNFalpha-induced osteoclastogenesis | Q40666297 | ||
| G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. | Q40724468 | ||
| Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function | Q40736018 | ||
| Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction | Q41927546 | ||
| Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses | Q42488424 | ||
| Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways | Q42494588 | ||
| Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment | Q43181439 | ||
| Bifurcation of osteoclasts and dendritic cells from common progenitors | Q43757343 | ||
| Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin | Q43937881 | ||
| P304 | page(s) | 149-165 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Advances in Immunology | Q15752932 |
| P1476 | title | Osteoimmunology: a view from the bone | |
| P478 | volume | 95 |
| Q36838568 | Dendritic cell-mediated in vivo bone resorption. |
| Q48530248 | Factors associated with low bone density among women with major depressive disorder |
| Q37829690 | Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications |
| Q39318199 | Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. |
| Q41985907 | Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection |
| Q34305347 | Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro. |
| Q36949734 | Osteoclasts and CD8 T cells form a negative feedback loop that contributes to homeostasis of both the skeletal and immune systems |
| Q28301682 | Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis |
| Q35085107 | TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB. |
| Q55717414 | The P2X7 receptor: a key player in immune-mediated bone loss? |
| Q91899943 | The Role of Immune Regulatory Cells in Nontraumatic Osteonecrosis of the Femoral Head: A Retrospective Clinical Study |
| Q37806610 | The multiple faces of autoimmune-mediated bone loss |
Search more.